Target Validation Information
TTD ID	T19579
Target Name	Interleukin 2 receptor beta (IL2RB)
Type of Target	Clinical trial
Action against Disease Model	Medusa IL-2	Drug Info	The potency of IL-2 is EC50 = 20.2+/-1.3 and 22.0+/-1.3 u/ml in Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients respectively	[1]
References
REF 1	Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2. Naunyn Schmiedebergs Arch Pharmacol. 1998 Sep;358(3):382-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.